Sarepta Therapeutics
SRPT
$127.39
Share price
2.53%
Change (1 day)
3.32%
Change (1 year)
Categories
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.
EPS for Sarepta Therapeutics (SRPT)
EPS in 2023 (TTM): -$7.83
According to Sarepta Therapeutics 's latest financial reports the company's current EPS (TTM) is -$7.83. In 2022 the company made an earnings per share (EPS) of -$8.03 a decrease over its 2021 EPS that were of -$5.15.
EPS history for Sarepta Therapeutics from 2001 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$7.83 | -2.49% |
| 2022 | -$8.03 | 55.92% |
| 2021 | -$5.15 | -27.16% |
| 2020 | -$7.07 | -26.96% |
| 2019 | -$9.68 | 78.6% |
| 2018 | -$5.42 | 603.9% |
| 2017 | -$0.77 | -85.9% |
| 2016 | -$5.46 | 5.2% |
| 2015 | -$5.19 | 53.1% |
| 2014 | -$3.39 | -0% |
| 2013 | -$3.39 | -33.79% |
| 2012 | -$5.12 | 7214.29% |
| 2011 | -$0.07000 | -96.11% |
| 2010 | -$1.80 | 15.38% |
| 2009 | -$1.56 | -23.53% |
| 2008 | -$2.04 | -37.04% |
| 2007 | -$3.24 | -0% |
| 2006 | -$3.24 | 45.95% |
| 2005 | -$2.22 | -46.38% |
| 2004 | -$4.14 | 40.82% |
| 2003 | -$2.94 | -57.02% |
| 2002 | -$6.84 | -2.56% |
| 2001 | -$7.02 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Gilead Sciences GILD | $4.39 | -156.07% | 🇺🇸 USA |
 PTC Therapeutics
PTCT | -$8.65 | 10.47% | 🇺🇸 USA |
 Novavax NVAX | -$7.19 | -8.17% | 🇺🇸 USA |
 Alnylam Pharmaceuticals
ALNY | -$4.11 | -47.51% | 🇺🇸 USA |
 Insmed INSM | -$5.27 | -32.69% | 🇺🇸 USA |
 BioCryst Pharmaceuticals
BCRX | -$1.25 | -84.04% | 🇺🇸 USA |
 Avidity Biosciences RNA | -$3.10 | -60.41% | 🇺🇸 USA |